Latest Financial Performance News

Cadence Opportunities Fund Limited has reported a remarkable turnaround for the half-year ending December 2025, posting a $6.4 million profit and raising its interim dividend to 7.5 cents per share.

Cadence Capital Limited has reported a remarkable turnaround with a 508% surge in profit after tax for the half-year ended December 2025, alongside a fully franked interim dividend declaration.

London City Equities Limited reported a 38% revenue increase and a $5.6 million capital gain from asset sales, while boosting liquidity to nearly 60% of its portfolio and raising dividends amid a cautious investment outlook.

BSA Limited reported an 84% plunge in revenue for the half-year ending December 2025, driven by lost contracts and reduced volumes, yet managed a $6.3 million profit amid restructuring and cost controls. Significant board changes signal a strategic reset as the company navigates uncertain waters.

Rural Funds Group has reported a striking 292% surge in profit after tax for the half year ending December 2025, alongside a 13% rise in revenue, signalling robust growth in its agricultural property portfolio.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.

Cobram Estate Olives reported a widened half-year loss driven by higher oil costs and operating expenses, while progressing its US growth strategy with a major California acquisition.

WAM Strategic Value Limited has reported a robust half-year performance, with net profit soaring 158.6% and an increased fully franked interim dividend. The company’s investment portfolio outperformed the market, underpinning strong shareholder returns.

Energy Resources of Australia reported a significantly reduced net loss of $50 million for 2025, driven by rehabilitation provision adjustments and higher interest income. Meanwhile, rehabilitation delays and Rio Tinto’s compulsory acquisition efforts highlight ongoing operational and ownership challenges.

L1 Long Short Fund Limited has reported a robust turnaround with a $415 million net profit for the half-year ending December 2025, declaring a fully franked interim dividend of 3.6 cents per share.

MyState Limited reported a robust half-year result with a 61% rise in underlying net profit, driven by the full impact of its Auswide Bank merger and strong growth across key business lines. The company also declared a fully franked interim dividend of 12 cents per share.

AdAlta Limited reported a $2.44 million loss for H1 FY26 while progressing a key CAR-T therapy collaboration and raising $2.8 million in capital. The company’s ‘East to West’ immunotherapy strategy gains momentum with regulatory tailwinds and cost efficiencies.